The Cancer Community's Next Steps for the Moonshot Initiative

The National Cancer Moonshot Initiative’s Blue Ribbon Panel is moving quickly to develop recommendations on how to accelerate progress against...

New on NCI’s Websites for May 2016

NCI is constantly publishing new information on its websites, so periodically we provide updates on new content of interest to...

Venetoclax Approved for Some Patients with Chronic Lymphocytic Leukemia

The FDA has approved venetoclax for patients with chronic lymphocytic leukemia whose tumors have a specific genetic alteration. Source link

After Rising for Decades, Thyroid Cancer Incidence Stabilizes

After rising steadily since the 1990s, the incidence of thyroid cancer in the United States may be leveling off, according...

Calling on Data Enthusiasts to Help Advance Cancer Research

Health data enthusiasts of all stripes were in Washington, D.C., today for Health Datapalooza. NCI’s Dr. Warren Kibbe explains that...

Shedding Pounds With Acai Berry – Lose Weight Without Exercise Or Medication!

Do you know the "next big thing" in the world of dieting? The answer is Acai berry! With Acai berry,...

New Treatment Target Identified for Diffuse Large B-Cell Lymphoma

NCI researchers have identified new therapeutic targets for diffuse large B-cell lymphoma. Drugs that hit these targets are under clinical...

Crosstalk between Cancer Cells and Neighboring Cells May Contribute to Tumor Growth

Pancreatic cancer cells and neighboring normal cells engage in a two-way molecular conversation that helps drive malignant behavior in the...

Improving Cancer Control in Rural Communities: An Interview with Dr. Robert Croyle

NCI’s Dr. Robert Croyle discusses some of the issues related to cancer control faced by rural communities and how NCI...